Results 221 to 230 of about 47,601 (323)
Persistent glycolysis defines pathological foreign body-associated inflammation to polymeric implants. [PDF]
Rempe C +10 more
europepmc +1 more source
USP28 Promotes Osimertinib Resistance in H1975 NSCLC Cells by Deubiquitinating and Stabilizing SIRT1
ABSTRACT Osimertinib (OSI) resistance in non‐small cell lung cancer (NSCLC) remains a significant challenge. This report explored the precise role of USP28 on OSI resistance in NSCLC and identified a functional downstream effector. OSI‐resistant H1975 cells (H1975/OSI) were established by long‐term OSI exposure.
Hu‐Sen Fan +4 more
wiley +1 more source
Key Early Changes in Oral Squamous Cell Carcinogenesis Are Accelerated by Ectopic BMI1 Expression. [PDF]
Baquero J +5 more
europepmc +1 more source
Studies of renal injury IV: The GLUT1 gene protects renal cells from cyclosporine A toxicity [PDF]
Jesus H. Dominguez +2 more
openalex +1 more source
Mass spectrometry in ocular drug research
Abstract Mass spectrometry (MS) has been proven as an excellent tool in ocular drug research allowing analyzes from small samples and low concentrations. This review begins with a short introduction to eye physiology and ocular pharmacokinetics and the relevance of advancing ophthalmic treatments.
Eva M. del Amo +6 more
wiley +1 more source
Prevalence of GLUT1 overexpression in human cancers a systematic review and meta analysis. [PDF]
Yuan Q +7 more
europepmc +1 more source
We identified first time a critical m6A modification of circIST1 on miR‐140‐3p/miR‐182‐HIF1α regulatory network involved in the HCC progression and tumor glycolysis, gaining mechanistic insights into the function of circRNAs in HCC progression. ABSTRACT The involvement of circular RNAs (circRNAs) have been well‐documented in various cancers, including ...
Yangyang Zhan +12 more
wiley +1 more source
Targeting Glucose Transporter 1 (GLUT1) in Cancer: Molecular Mechanisms and Nanomedicine Applications. [PDF]
Ren Z, Zhao J, Li S, Yuan H.
europepmc +1 more source
Scheme and pathological characteristics of the CheckRad‐CD8 trial cohort used for the transcriptome analyses. (A) Flow diagram depicting the patient cohort and study scheme as the basis for whole transcriptome profiling of samples from locally advanced HNSCC patients treated with induction chemoimmunotherapy (iCIT).
Jian‐Guo Zhou +20 more
wiley +1 more source

